nanovibronix.com (NAOV): Market Cap to Revenue

Symbol and logo of brand NanoVibronix Inc. (NAOV)

NanoVibronix, Inc. (NAOV) develops patent-protected devices to combat catheter-associated infections, ensuring high profitability. The price-to-sales trend on the GURU.Markets chart confirms this trajectory, with the metric recorded at 1.60. The company is implementing ultrasound therapy for drug-free wound healing, leveraging a streamlined internal warehouse system to ensure stable supplies to clinics.

NAOV NanoVibronix Inc. P/S Multiple (07/04/2022 - 12/12/2025)

Analytical breakdowns for NanoVibronix Inc. (NAOV)

- share price and consensus valuation forecast:
Price Performance Chart nanovibronix.com|NAOV - Price Target Chart
- stock exchange capitalization data:
Market Valuation NanoVibronix, Inc.|NAOV - Enterprise Value
- book value of equity indicators:
Net Asset Value per Share NanoVibronix|NAOV - Book Capitalization|Capitalization to Book Value Ratio nanovibronix.com|NAOV - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient NanoVibronix, Inc.|NAOV - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio NanoVibronix|NAOV - Company Aggregate Debts|Debts to Book Capitalization NanoVibronix|NAOV - Company Long-Term Debt|Company Short-Term Debt NanoVibronix|Intermediate Coverage Ratio nanovibronix.com
- earnings and multiples data:
NAOV - Net Profit|Expected Net Profit NanoVibronix, Inc.|NAOV - Price to Earnings Ratio|Forward Price to Earnings Multiple NanoVibronix|NAOV - Price/Earnings to Growth Multiple|EV/EBITDA Multiple NanoVibronix, Inc.|NAOV - Operating profit EBITDA|Net earnings per share for the last four quarters NanoVibronix|NAOV - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months nanovibronix.com|NAOV - Earnings per share growth in current year|Expected earnings per share growth for next year NanoVibronix, Inc.
- issuer revenue and sales details:
NAOV - Revenue and Sales Volume|Company Expected Sales Volume NanoVibronix Inc.|NAOV - Price-to-Revenue Ratio|Market Cap to Projected Revenue NanoVibronix, Inc.|NAOV - Revenue Growth YoY (Last 12 Months)
General company analysis:NAOV nanovibronix.com
Core merchandise of NanoVibronix

Investors utilize this ratio as an indicator of market confidence in the company's future expansion rates. The ratio of market capitalization to annual revenue in the price/sales multiple allows for an assessment of the asset's premium, which is critical for NanoVibronix, Inc. (NAOV) due to the risks of slow acoustic technology adoption and reliance on insurance reimbursement systems amid limited marketing.

Competitors of NanoVibronix, Inc.

DXCM (DexCom Inc) - Market Capitalization-to-Revenue Ratio|P/S Multiple PEN (penumbrainc.com)|NOVT - Market Cap to Revenue|Haemonetics - P/S Multiple|Price to Sales Inspire Medical Systems|PRCT: P/S Multiple|Market Cap to Revenue Ratio CNMD|PLSE (Pulse Medical) - P/S Multiple|InMode Corp (INMD) - Price-to-Revenue Coefficient|P/S Multiple PMI|Market Cap to Revenue Surmodics, Inc. SRDX|P/S Multiple SENS (senseonics.com)|P/S Multiple NeuroPace Inc NPCE|TCMD - Price-to-Revenue Ratio|SNWV: Price-to-Revenue Ratio|Outset Medical Corp (OM) - Price-to-Revenue Ratio|SmartVest - Market Capitalization-to-Revenue Ratio|LNSR (LENSAR Inc) - P/S Multiple|Price to Sales AVITA Medical Inc. RCEL|Price-to-Revenue Ratio Profound Medical (PROF)|Baird Medical Corp (BDMD) - Price-to-Revenue Multiple|EDAP TMS SA - Market Cap to Revenue|P/S Multiple Bovie Medical APYX|IceCure Medical Ltd. - P/S Multiple|Price-to-Revenue Coefficient Pulmonx LUNG|TELA Bio (TELA) - Price-to-Revenue Ratio|Price-to-Sales Ratio CTSO (CytoSorbents Corp.)|Price-to-Revenue Ratio sensushealthcare.com|Market Cap to Revenue Zynex, Inc. (ZYXI)|P/S Multiple ECOR|RBOT - Price to Sales|Price-to-Revenue Ratio inspira-technologies.com IINN|Market Cap to Sales Volume ICU (SeaStar Medical Holding Corp.)|IRIX: Market Cap to Revenue|ibs.inc - Market Cap to Sales Volume|XAIR: P/S Multiple|Price-to-Sales Ratio PFSA (Profusa Inc.)|Market Cap to Revenue SSKN|Price-to-Revenue Ratio GCTK|Price-to-Revenue Ratio Venus Concept (VERO)|Market Cap to Revenue Nuwellis, Inc. NUWE|P/S Multiple AEMD (Aethlon Medical, Inc.)|ASXC: Market Cap to Revenue Ratio|Avinger Inc. - P/S Multiple|Price-to-Revenue Coefficient BioSig Technologies, Inc BSGM|CUTR: P/S Multiple|Know Labs, Inc. (KNW) - P/S Multiple|Price-to-Revenue Ratio Inari Medical Inc|Market Cap to Revenue Nevro Corp (NVRO)|Market Cap to Revenue RSLS (ReShape Lifesciences, Inc.)|P/S Multiple Silk Road Medical Inc. (SILK)